HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

gadofluorine P

a MRI contrast agent; structure in first source

Networked: 2 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Halogenated Hydrocarbons: 42
    - Fluorinated Hydrocarbons: 4
      - Fluorocarbons: 1209
        gadofluorine P: 2
- Coordination Complexes: 576
  - gadofluorine P: 2
Inorganic Chemicals: 9
- Coordination Complexes: 576
  - gadofluorine P: 2

Experts

1.	Aichler, Michaela: 2 articles (01/2020 - 04/2018)
2.	Botnar, René M: 2 articles (01/2020 - 04/2018)
3.	Buchholz, Rebecca: 2 articles (01/2020 - 04/2018)
4.	Faber, Cornelius: 2 articles (01/2020 - 04/2018)
5.	Feuchtinger, Annette: 2 articles (01/2020 - 04/2018)
6.	Glinzer, Almut: 2 articles (01/2020 - 04/2018)
7.	Huber, Katharina: 2 articles (01/2020 - 04/2018)
8.	Höltke, Carsten: 2 articles (01/2020 - 04/2018)
9.	Kaissis, Georgios: 2 articles (01/2020 - 04/2018)
10.	Karst, Uwe: 2 articles (01/2020 - 04/2018)

Related Diseases

1.	Cicatrix (Scar) 04/01/2018 - "To establish combined Magnetic Resonance Imaging (MRI) and Mass Spectrometry Imaging (MSI) for improved detection and quantification of Gadofluorine P deposition in scar formation and myocardial remodeling. " 04/01/2018 - "Both Gadofluorine P enhancement as well as local tissue content in the myocardial scar were highest at 15 minutes post injection. "
2.	Atherosclerotic Plaque (Atheroma) 01/01/2020 - "We therefore aimed to investigate the additive value of mass spectrometry imaging (MSI) of atherosclerosis-affine Gadofluorine P for molecular MRI of atherosclerotic plaques. "
3.	Atherosclerosis 01/01/2020 - "Mass spectrometry imaging allowed to visualize the localization and measure the concentration of the MR imaging probe Gadofluorine P in plaque tissue ex vivo with high spatial resolution and thus adds novel and more target specific information to molecular MR imaging of atherosclerosis." 01/01/2020 - "Atherosclerotic Ldlr-/- mice were investigated by high-field MRI (7 T) at different time points following injection of atherosclerosis-affine Gadofluorine P as well as at different stages of atherosclerosis formation (4, 8, 16 and 20 weeks of HFD). " 01/01/2020 - "We therefore aimed to investigate the additive value of mass spectrometry imaging (MSI) of atherosclerosis-affine Gadofluorine P for molecular MRI of atherosclerotic plaques. "
4.	Myocardial Infarction 04/01/2018 - "Molecular imaging of myocardial infarction with Gadofluorine P - A combined magnetic resonance and mass spectrometry imaging approach."
5.	Infarction (Infarctions) 04/01/2018 - "R1 values increased from 1 to 6 weeks after MI (1.62 s-1 vs 2.68 s-1, p = 0.059) paralleled by an increase in Gadofluorine P concentration in the infarct from 0.019 mM at 1 week to 0.028 mM at 6 weeks (p = 0.048), whereas Gd-DTPA enhancement showed no differences (3.95 s-1 vs 3.47 s-1, p = 0.701). "

Related Drugs and Biologics

1.	Gadolinium DTPA (Magnevist)